BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2021

View Archived Issues

NeuBase reports on three programs with PATrOL-enabled genetic medicines

Read More

New GLP-1 receptor agonists identified at ILDONG Pharmaceutical

Read More

Yuhan Corp. describes compositions including GDF15 variants

Read More

Bayer patents prostaglandin E2 receptor EP3 subtype antagonists

Read More

New tucaresol prodrugs discovered at Beyondspring Pharmaceuticals

Read More

Gilead discovers Mcl-1 inhibitors

Read More

Peptide-drug conjugate PEN-221 demonstrates efficacy in patients with GI neuroendocrine tumors

Read More

Lilly's SERD LY-3484356 well tolerated in first-in-human study

Read More

Urinary CCL5 mRNA is predictive of diabetic nephropathy progression

Read More

Shoreline and BeiGene collaborate to develop and commercialize NK-based cell therapies

Read More

ReNeuron provides update for hRPC therapy candidate study

Read More

ONK Therapeutics and Trinity College Dublin collaborate in an Enterprise Ireland funded project

Read More

First patient dosed in phase I study of BTX-A51 in advanced solid tumors

Read More

Two-year follow-up data from phase I/IIa study of LiPax in non-muscle invasive bladder cancer

Read More

TAS-3681 shows safety and antitumor activity against heavily pretreated, multidrug-resistant mCRPC

Read More

Atossa presents final data from phase II endoxifen breast cancer study

Read More

First European CTA accepted for phase I/II study of INZ-701 in ABCC6 deficiency

Read More

InCarda announces progress in development program for InRhythm

Read More

Preliminary phase I results reported for OMS-906

Read More

Phase I trial evaluates M-4076 in advanced solid tumors

Read More

GigaGen initiates first-in-human study of GIGA-2050 in COVID-19

Read More

Urinary DKK3 is a biomarker of CKD progression and mortality

Read More

At ASCO, radiopharmaceuticals score with lutetium-PSMA

Read More

Oxurion receives IRB approval for phase II study of THR-687 in DME

Read More

IMDC recommends continuation of phase IIb study of nangibotide in septic shock

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing